Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Association between serum ferritin and mortality: findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study.

Karaboyas A, Morgenstern H, Pisoni RL, Zee J, Vanholder R, Jacobson SH, Inaba M, Loram LC, Port FK, Robinson BM.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2234-2244. doi: 10.1093/ndt/gfy190.

2.

Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Robinson BM, Larkina M, Bieber B, Kleophas W, Li Y, Locatelli F, McCullough KP, Nolen JG, Port FK, Pisoni RL.

BMC Nephrol. 2017 Nov 9;18(1):330. doi: 10.1186/s12882-017-0745-9.

3.

Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing.

Karaboyas A, Zee J, Morgenstern H, Nolen JG, Hakim R, Kalantar-Zadeh K, Zager P, Pisoni RL, Port FK, Robinson BM.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1814-21. doi: 10.2215/CJN.02600315. Epub 2015 Aug 18.

4.

Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Bailie GR, Larkina M, Goodkin DA, Li Y, Pisoni RL, Bieber B, Mason N, Tong L, Locatelli F, Marshall MR, Inaba M, Robinson BM.

Nephrol Dial Transplant. 2013 Oct;28(10):2570-9. doi: 10.1093/ndt/gft062.

PMID:
24078642
5.

Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease [Internet].

Chung M, Moorthy D, Hadar N, Salvi P, Iovin RC, Lau J.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Oct.

6.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
7.

Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation.

Shoji T, Niihata K, Fukuma S, Fukuhara S, Akizawa T, Inaba M.

Clin Exp Nephrol. 2017 Aug;21(4):685-693. doi: 10.1007/s10157-016-1317-1. Epub 2016 Aug 8.

8.

A comprehensive vision for intravenous iron therapy.

Coyne DW.

Am J Kidney Dis. 2008 Dec;52(6 Suppl):S14-20. doi: 10.1053/j.ajkd.2008.09.003.

PMID:
19010257
9.

Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation.

Rambod M, Kovesdy CP, Kalantar-Zadeh K.

Clin J Am Soc Nephrol. 2008 Nov;3(6):1691-701. doi: 10.2215/CJN.01070308. Epub 2008 Oct 15.

10.

Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.

Ogawa C, Tsuchiya K, Tomosugi N, Kanda F, Maeda K, Maeda T.

PLoS One. 2017 Jun 29;12(6):e0179608. doi: 10.1371/journal.pone.0179608. eCollection 2017.

11.

The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysis
.

Umanath K, Greco B, Jalal DI, McFadden M, Sika M, Koury MJ, Niecestro R, Hunsicker LG, Greene T, Lewis JB, Dwyer JP.

Clin Nephrol. 2017 Mar;87 (2017)(3):124-133. doi: 10.5414/CN108924.

PMID:
28128726
12.

Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.

Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH.

Am J Kidney Dis. 2001 Mar;37(3):564-72.

PMID:
11228181
13.

It's time to compare anemia management strategies in hemodialysis.

Coyne DW.

Clin J Am Soc Nephrol. 2010 Apr;5(4):740-2. doi: 10.2215/CJN.02490409. Epub 2010 Mar 18.

14.

The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?

Kalantar-Zadeh K, Kalantar-Zadeh K, Lee GH.

Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S9-18. Review.

15.

Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.

Kim T, Streja E, Soohoo M, Rhee CM, Eriguchi R, Kim TW, Chang TI, Obi Y, Kovesdy CP, Kalantar-Zadeh K.

Am J Nephrol. 2017;46(2):120-130. doi: 10.1159/000478735. Epub 2017 Jul 14.

16.

Anemia management trends in hospital-based dialysis centers (HBDCs), 2010 to 2013.

Coritsidis GN, Maglinte GA, Acharya A, Saxena A, Chang CL, Hill J, Gitlin M, Lafayette RA.

Clin Ther. 2014 Mar 1;36(3):408-18. doi: 10.1016/j.clinthera.2014.01.015. Epub 2014 Feb 28.

PMID:
24582713
17.

Thresholds of iron markers for iron deficiency erythropoiesis-finding of the Japanese nationwide dialysis registry.

Hamano T, Fujii N, Hayashi T, Yamamoto H, Iseki K, Tsubakihara Y.

Kidney Int Suppl (2011). 2015 Jun;5(1):23-32.

18.

Iron supplementation and mortality in incident dialysis patients: an observational study.

Zitt E, Sturm G, Kronenberg F, Neyer U, Knoll F, Lhotta K, Weiss G.

PLoS One. 2014 Dec 2;9(12):e114144. doi: 10.1371/journal.pone.0114144. eCollection 2014.

19.

Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.

Majoni SW, Ellis JA, Hall H, Abeyaratne A, Lawton PD.

Hemodial Int. 2014 Oct;18(4):740-50. doi: 10.1111/hdi.12173. Epub 2014 Apr 27.

PMID:
24766376
20.

The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry.

Maruyama Y, Yokoyama K, Yokoo T, Shigematsu T, Iseki K, Tsubakihara Y.

PLoS One. 2015 Nov 23;10(11):e0143430. doi: 10.1371/journal.pone.0143430. eCollection 2015.

Supplemental Content

Support Center